Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ann Banke

Showing results (11-20 of 24) with videos related to

Pageof 3
Sort By:
European Journal of Cardiovascular Nursing|November 21, 2019
Patient-reported outcomes at hospital discharge among patients with arrhythmia: Results from the national DenHeart surveyLars Thrysoee, Charlotte Brun Thorup, Trine Bernholdt Rasmussen, et al.
European Journal of Heart Failure|January 12, 2016
Incidence of cancer in patients with chronic heart failure: a long-term follow-up studyAnn Banke, Morten Schou, Lars Videbaek, et al.
American Heart Journal|July 15, 2023
Importance of familial predisposition to heart failure to the risk of anthracycline-related cardiotoxicity: A nationwide studyAnn Banke, Charlotte Andersson, Maria D'Souza, et al.
Journal of Cardiovascular Translational Research|May 12, 2021
Impella RP Versus Pharmacologic Vasoactive Treatment in Profound Cardiogenic Shock due to Right Ventricular FailureJakob Josiassen, Ole K L Helgestad, Nanna L J Udesen, et al.
JACC. Heart Failure|March 2, 2019
Long-Term Risk of Heart Failure in Breast Cancer Patients After Adjuvant Chemotherapy With or Without TrastuzumabAnn Banke, Emil L Fosbøl, Marianne Ewertz, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|November 13, 2018
Impella CP or VA-ECMO in profound cardiogenic shock: left ventricular unloading and organ perfusion in a large animal modelOle Kristian Møller-Helgestad, Janus A Hyldebrandt, Ann Banke, et al.
Journal of the American Heart Association|February 3, 2023
Impact of Impella RP Versus Vasoactive Treatment on Right and Left Ventricular Strain in a Porcine Model of Acute Cardiogenic Shock Induced by Right Coronary Artery EmbolizationPeter H Frederiksen, Jakob Josiassen, Nanna L J Udesen, et al.
Intensive Care Medicine Experimental|August 14, 2020
Unloading using Impella CP during profound cardiogenic shock caused by left ventricular failure in a large animal model: impact on the right ventricleJakob Josiassen, Ole Kristian Lerche Helgestad, Nanne Louise Junker Udesen, et al.
Clinical Epidemiology|September 30, 2024
Excess Risk of Mortality and Hospitalization in Patients with Heart Failure According to Age and Comorbidity - A Nationwide Register StudyChristian Madelaire, Thomas Gerds, Lars Køber, et al.
Plos One|May 22, 2026
Hemodynamic effects of prophylactic amiodarone assessed by pressure-volume analysis in anesthetized female pigs in sinus rhythm-An exploratory studyLaura Svanekjær, Emma Illum, Peter H Frederiksen, et al.
Pageof 3

Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
European Journal of Cardiovascular Nursing|November 21, 2019
Patient-reported outcomes at hospital discharge among patients with arrhythmia: Results from the national DenHeart surveyLars Thrysoee, Charlotte Brun Thorup, Trine Bernholdt Rasmussen, et al.
European Journal of Heart Failure|January 12, 2016
Incidence of cancer in patients with chronic heart failure: a long-term follow-up studyAnn Banke, Morten Schou, Lars Videbaek, et al.
American Heart Journal|July 15, 2023
Importance of familial predisposition to heart failure to the risk of anthracycline-related cardiotoxicity: A nationwide studyAnn Banke, Charlotte Andersson, Maria D'Souza, et al.
Journal of Cardiovascular Translational Research|May 12, 2021
Impella RP Versus Pharmacologic Vasoactive Treatment in Profound Cardiogenic Shock due to Right Ventricular FailureJakob Josiassen, Ole K L Helgestad, Nanna L J Udesen, et al.
JACC. Heart Failure|March 2, 2019
Long-Term Risk of Heart Failure in Breast Cancer Patients After Adjuvant Chemotherapy With or Without TrastuzumabAnn Banke, Emil L Fosbøl, Marianne Ewertz, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|November 13, 2018
Impella CP or VA-ECMO in profound cardiogenic shock: left ventricular unloading and organ perfusion in a large animal modelOle Kristian Møller-Helgestad, Janus A Hyldebrandt, Ann Banke, et al.
Journal of the American Heart Association|February 3, 2023
Impact of Impella RP Versus Vasoactive Treatment on Right and Left Ventricular Strain in a Porcine Model of Acute Cardiogenic Shock Induced by Right Coronary Artery EmbolizationPeter H Frederiksen, Jakob Josiassen, Nanna L J Udesen, et al.
Intensive Care Medicine Experimental|August 14, 2020
Unloading using Impella CP during profound cardiogenic shock caused by left ventricular failure in a large animal model: impact on the right ventricleJakob Josiassen, Ole Kristian Lerche Helgestad, Nanne Louise Junker Udesen, et al.
Clinical Epidemiology|September 30, 2024
Excess Risk of Mortality and Hospitalization in Patients with Heart Failure According to Age and Comorbidity - A Nationwide Register StudyChristian Madelaire, Thomas Gerds, Lars Køber, et al.
Plos One|May 22, 2026
Hemodynamic effects of prophylactic amiodarone assessed by pressure-volume analysis in anesthetized female pigs in sinus rhythm-An exploratory studyLaura Svanekjær, Emma Illum, Peter H Frederiksen, et al.
Pageof 3